Telemetry Investments, L.L.C. Bristol Myers Squibb CO Transaction History

Telemetry Investments, L.L.C.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$57.74 - $65.43 $219,412 - $248,634	-3,800 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$57.43 - $63.64 $218,234 - $241,832	3,800 New	3,800 $229,000
Q2 2019 Aug 14, 2019	SELL	$44.62 - $49.34 $281,106 - $310,842	-6,300 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $284,256 - $338,940	6,300 New	6,300 $301,000

2,400

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $108B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Telemetry Investments, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Telemetry Investments, L.L.C. with notifications on news.